• 272 Citations
  • 8 h-Index
20052018
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Daniela Gilardi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 10 Similar Profiles
Ulcerative Colitis Medicine & Life Sciences
Crohn Disease Medicine & Life Sciences
Inflammatory Bowel Diseases Medicine & Life Sciences
Interleukin-23 Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Safety Medicine & Life Sciences
Biosimilar Pharmaceuticals Medicine & Life Sciences
Breast Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2005 2018

  • 272 Citations
  • 8 h-Index
  • 15 Article
  • 7 Review article
  • 1 Letter
3 Citations (Scopus)

Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study

Allocca, M., Fiorino, G., Bonovas, S., Furfaro, F., Gilardi, D., Argollo, M., Magnoni, P., Peyrin-Biroulet, L. & Danese, S., Nov 28 2018, In : Journal of Crohn's & colitis. 12, 12, p. 1385-1391 7 p.

Research output: Contribution to journalArticle

Ulcerative Colitis
Prospective Studies
Colonoscopy
Lymph Nodes
Colitis
4 Citations (Scopus)
Interleukin-23
Ulcerative Colitis
Th17 Cells
Interleukin-12 Subunit p40
Drug and Narcotic Control
7 Citations (Scopus)
Colonoscopy
Crohn Disease
Magnetic Resonance Spectroscopy
Abscess
Fistula
10 Citations (Scopus)

Full interchangeability in regard to immunogenicity between the infliximab reference biologic and biosimilars CT-P13 and SB2 in inflammatory bowel disease

Fiorino, G., Ruiz-Arguello, M. B., Maguregui, A., Nagore, D., Correale, C., Radice, S., Gilardi, D., Allocca, M., Furfaro, F., Martínez, A. & Danese, S., Feb 16 2018, In : Inflammatory Bowel Diseases. 24, 3, p. 601-606 6 p.

Research output: Contribution to journalArticle

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Antibodies
CT-P13
Infliximab
4 Citations (Scopus)

JAK inhibitors: Novel developments in management of ulcerative colitis

Fiorino, G., D'Amico, F., Italia, A., Gilardi, D., Furfaro, F. & Danese, S., Feb 1 2018, In : Best Practice and Research: Clinical Gastroenterology. 32-33, p. 89-93 5 p.

Research output: Contribution to journalReview article

Ulcerative Colitis
Janus Kinases
Signal Transduction
Clinical Trials
Cytokines